Kontafarma China
Kontafarma China, officially known as Kontafarma Limited, is a prominent player in the pharmaceutical and healthcare industry, headquartered in Hong Kong. Founded in 2005, the company has established a strong presence across Asia, focusing on the development and distribution of innovative healthcare solutions. Specialising in prescription medications, over-the-counter products, and health supplements, Kontafarma is recognised for its commitment to quality and efficacy. The company’s unique approach combines advanced research with a deep understanding of local market needs, allowing it to deliver tailored solutions that enhance patient care. With a reputation for excellence, Kontafarma has achieved significant milestones, including strategic partnerships and a growing portfolio of proprietary products. As a trusted name in the industry, Kontafarma continues to strengthen its market position, contributing to the advancement of healthcare in the region.
DitchCarbon Score
How does Kontafarma China's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kontafarma China's score of 27 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kontafarma China's reported carbon emissions
In 2023, Kontafarma China, headquartered in Hong Kong, reported total carbon emissions of approximately 1,057,000 kg CO2e for Scope 1 and about 727,000 kg CO2e for Scope 2. This marks a significant reduction from 2022, where emissions were approximately 2,110,000 kg CO2e for Scope 1 and about 804,000 kg CO2e for Scope 2. The company has not disclosed any Scope 3 emissions data for 2023, but in 2021, it reported approximately 4,034,000 kg CO2e in this category. Kontafarma has not set specific reduction targets or climate pledges, indicating a potential area for future commitment in line with industry standards for climate action. Overall, Kontafarma's emissions data reflects a trend towards reduction, particularly in Scope 1 emissions, which is crucial for their climate strategy moving forward.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 25,042,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 9,935,000 | 0,000,000 | 0,000,000 | 000,000 | 000,000 |
| Scope 3 | 3,034,000 | 0,000,000 | 0,000,000 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kontafarma China is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
